Mukesh Ambani emerges richest Indian for 11th consecutive year in Forbes list

New Delhi, Jun 24: Union Civil Aviation Minister Hardeep Singh Puri on Tuesday said that nearly 1,25,000 Indians have returned from different countries under the Vande Bharat Mission.

He informed that 6,037 people returned to India from overseas on June 23.

"Vande Bharat continues to be a mission of hope and happiness for stranded and distressed Indians around the world. So far, nearly 125K Indians have come back on these evacuation flights and nearly 43K have flown out of India. Today (on Tuesday) 6,037 people returned from different countries," Puri said in a tweet.

As many as 2,50,087 Indian nationals stranded abroad have been repatriated since the beginning of Vande Bharat Mission last month, the Ministry of External Affairs (MEA) said last week.

The Vande Bharat Mission, which started from May 7 to evacuate Indians stranded abroad due to coronavirus pandemic, is in its third phase.
The recent phase commenced on June 11.

Under the third phase, India would have 550 flights including 191 feeder flights.

Bengaluru, Apr 30: Shares of Glenmark Pharmaceuticals Ltd rose almost 9% on Thursday after the Indian drugmaker got an approval to conduct clinical trials with antiviral drug favipiravir, seen as a potential treatment for COVID-19.

Favipiravir, manufactured under the brand name Avigan by a unit of Japan's Fujifilm Holdings Corp and approved for use as an anti-flu drug in the Asian island country in 2014, has been effective, with no obvious side-effects, in helping coronavirus patients recover, a Chinese official told reporters at a news conference last month.

"After having successfully developed the API and the formulations ... Glenmark is all geared to immediately begin clinical trials on favipiravir on COVID-19 patients in India," Sushrut Kulkarni, executive vice-president for Global R&D, Glenmark Pharmaceuticals, said in a statement. 

The Drug Controller General of India, the country's drug regulator, did not immediately respond to Reuters request for comment.

On Wednesday, another Indian pharmaceutical company, Strides Pharma Science Ltd, said it had developed and commercialized favipiravir antiviral tablets, and had applied to Indian drug authorities to start trials.

Shares of Mumbai-based Glenmark Pharmaceuticals, which rose as much as 8.9% to 359 rupees ($4.78), was trading up 5.9%, as of 0407 GMT.

Patna, Jan 23: "They should go wherever they want," Bihar Chief Minister and JDU supremo Nitish Kumar said on Thursday when asked of Prashant Kishor and Pavan Verma's repeated questions about the party's stand's on the newly enacted Citizenship Act.

"It is their personal decision. They should go wherever they want. We don't have an objection. Don't look at JDU in the context of statements by some people. JDU works with determination. We have a clear stand and don't have any confusion," the Chief Minister told reporters here.

"If they have something to tell, they should come and discuss it within the party. They should go wherever they want. They have my good wishes," he said.

JDU spokesperson and national general secretary Pavan Verma has questioned his party's alliance with the BJP in Delhi Assembly polls while Kishor has more than once made his differences with the party known on the issue of the amended Citizenship Act, and National Register of Citizens.